Brokaw George R 4

What Happened

• George R. Brokaw, a director of Chemours Co. (CC), was granted 7,182 shares/units on 2026-05-06. The transaction is reported as an award/grant (code A) with a reported acquisition price of $0.00, indicating a compensation award rather than an open-market purchase or sale. The filing notes these include deferred stock units and dividend equivalent units.

Key Details

• Transaction date: 2026-05-06; Form 4 filed: 2026-05-08.
• Transaction type/code: Award/Grant (A); reported price per share/unit: $0.00.
• Shares/units acquired: 7,182 (includes deferred stock units and dividend equivalent units — see footnote).
• Shares owned after transaction: Not specified in this Form 4.
• Filing timeliness: Filed two days after the transaction (not marked late).

Context

• This was a compensation award (deferred stock/dividend-equivalent units). Such grants reflect company compensation practices and vesting/deferral arrangements rather than a director buying or selling stock in the market; they are not a direct bullish purchase signal. Dividend equivalent units typically track dividend value on deferred shares until settlement.